It's a nootropic drug invented in 1996 by a staff working for Merck, Sharp and Dohme, that was the very first compound developed which acts to be a subtype-selective inverse agonist within the ?five subtype from the benzodiazepine binding internet site to the GABAA receptor.The existence of every drug was subsequently confirmed by the use of refere